| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.0009 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.003 |